P-Cure Secures CE Marking for Breakthrough Image Guided Positioning System

P-Cure Ltd (Shilat, Israel), a developer and supplier of the comprehensive 360°-gantry-less adaptive proton therapy solution, announced that the European Parliament approved the CE marking for the P-ARTIS System enabling the company to market and sell the product in Europe. The P-ARTIS System is a vital development for enhanced patient treatment and is part of the newly developed full P-Cure proton therapy system currently being submitted for FDA clearance.

P-ARTIS is the only 360°-gantry-less image guided positioning system that enables planning and performs accurate image guided positioning of patients in the seated position for radiation therapy in general, and proton therapy in particular. The unique system for the first time brings to market a solution that allows for virtually limitless use of proton therapy in a gantry-less, compact configuration that fits into any radiation oncology department reducing the capital and operating costs. The solution includes an in-room vertical 4D CT, real time x-ray, robotic Six Degrees of Freedom positioning, and software that orchestrates the integrated operation of the patient-centric system.

Use of P-ARTIS 360°-gantry-less solution significantly enhances the possibility of bringing the benefits of proton therapy to patients around the world. The availability of proton therapy is severely limited because of the high capital costs, resulting in its being available to less than one percent of patients who could potentially benefit from it. According to Michael Marash, P-Cure CEO, “The P-Cure System will expand the availability of proton therapy with improved clinical outcomes to all cancer care institutions. By using our system, more healthcare providers will be able to integrate the technology, and more patients will gain access to this life saving technology. For the first time, the P-Cure System will substantially reduce the cost and size of a single room or multi-room expandable center, and dramatically reduce the time from planning to treatment.”